Search This Blog

Monday, October 31, 2022

RBC Cuts Price Target on Amedisys to $139 From $165 After 'Difficult' Q3

 Maintains Outperform Rating

https://www.marketscreener.com/quote/stock/AMEDISYS-INC-8342/news/RBC-Cuts-Price-Target-on-Amedisys-to-139-From-165-After-Difficult-Q3-Maintains-Outperform-Ratin-42135800/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.